Extensive Surgical and Comprehensive Postoperative Medical Management for Cystic Fibrosis Chronic Rhinosinusitis

Abstract

Background

Chronic rhinosinusitis has a major impact on the quality of life of patients with cystic fibrosis (CF) and may contribute to progression of chronic lung disease. Despite multiple sinus surgeries, maxillary sinus involvement is a recurrent problem. The modified endoscopic medial maxillectomy (MEMM) permits debridement in the clinic, improves mucus clearance with nasal irrigations, and increases access for topical delivery of therapeutics. However, clinical outcomes of aggressive sinus surgery with regimented postoperative medical treatment have not been systematically evaluated.

Methods

CF patients completed the 22-Item Sinonasal Outcome Test questionnaires before sinus surgery (and bilateral MEMM) and at sequential postoperative visits. Objective measures included Lund-Kennedy endoscopic score and pulmonary function tests (forced expiratory volume at 1 second percent [FEV₁%] predicted). Culture-directed antibiotic therapy, prednisone, and topical irrigations were initiated postoperatively.

Results

Twenty-two patients (mean age, 26.5 years; 4.9 prior sinus operations) underwent MEMM and sinus surgery. Symptom scores were significantly reduced at 60 days (primary outcome, 64.7 ± 18.4 presurgery versus 27.5 ± 15.3 postsurgery; p < 0.0001) and up to a year postoperatively (27.6 ± 12.6; p < 0.0001). Endoscopic scores were also reduced after surgery (10.4 ± 1.1 presurgery versus 5.7 ± 2.4 [30 days], 5.7 ± 1.4 [60 days], 5.8 ± 1.3 [120 days], and 6.0 ± 1.1 [1 year]; p < 0.0001)]. There were no differences in FEV₁% predicted up to 1 year postoperatively, but hospital admissions secondary to pulmonary exacerbations significantly decreased (2.0 ± 1.4 versus 3.2 ± 2.4, respectively; p < 0.05).

Conclusion

Prospective evaluation indicates sinus surgery with MEMM is associated with marked improvement in sinus disease outcomes. Additional studies are necessary to confirm whether this treatment paradigm is associated with improved CF pulmonary disease.

Get full access to this article

View all access options for this article.

References

Rowe

S.M.

, Miller

, and Sorscher

E.J.

. Cystic fibrosis. N Engl J Med 352: 1992–2001, 2005.

Brihaye

, Clement

P.A.

, Dab

. Pathological changes of the lateral nasal wall in patients with cystic fibrosis (mucoviscidosis). Int J Pediatr Otorhinolaryngol 28: 141–147, 1994.

Cepero

, Smith

R.J.

, Catlin

F.I.

. Cystic fibrosis—An otolaryngologic perspective. Otolaryngol Head Neck Surg 97: 356–360, 1987.

Gentile

V.G.

, and Isaacson

. Patterns of sinusitis in cystic fibrosis. Laryngoscope 106: 1005–1009, 1996.

Rosbe

K.W.

, Jones

D.T.

, Rahbar

. Endoscopic sinus surgery in cystic fibrosis: Do patients benefit from surgery? Int J Pediatr Otorhinolaryngol 61: 113–119, 2001.

Regnis

J.A.

, Robinson

, Bailey

D.L.

. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 150: 66–71, 1994.

Kingdom

T.T.

, Lee

K.C.

, FitzSimmons

S.C.

. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis requiring surgery. Arch Otolaryngol Head Neck Surg 122: 1209–1213, 1996.

Ramsey

, and Richardson

M.A.

. Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol 90: 547–552, 1992.

Jaffe

B.F.

, Strome

, Khaw

K.T.

. Nasal polypectomy and sinus surgery for cystic fibrosis—A 10 year review. Otolaryngol Clin North Am 10: 81–90, 1977.

10.

Woodworth

B.A.

, Ahn

, Flume

P.A.

. The delta F508 mutation in cystic fibrosis and impact on sinus development. Am J Rhinol 21: 122–127, 2007.

11.

Benninger

M.S.

, Ferguson

B.J.

, Hadley

J.A.

. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129: S1–S32, 2003.

12.

Payne

S.C.

. Empty nose syndrome: What are we really talking about? Otolaryngol Clin North Am 42: 331–337, ix–x, 2009.

13.

Hopkins

, Gillett

, Slack

. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 34: 447–454, 2009.

14.

Piccirillo

J.F.

, Thawley

S.E.

, Haiduk

. Indications for sinus surgery: How appropriate are the guidelines? Laryngoscope 108: 332–338, 1998.

15.

Lund

V.J.

, and Kennedy

D.W.

. Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl 167: 17–21, 1995.

16.

Lin

S.H.

, Kuo

P.H.

, Kuo

S.H.

. Severity staging of chronic obstructive pulmonary disease: Differences in pre- and post-bronchodilator spirometry. Yonsei Med J 50: 672–676, 2009.

17.

Lund

V.J.

, and Mackay

I.S.

. Staging in rhinosinusitus. Rhinology 31: 183–184, 1993.

18.

Holzmann

, Speich

, Kaufmann

. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: A 10-year experience. Transplantation 77: 134–136, 2004.

19.

Woodworth

B.A.

, Parker

R.O.

, and Schlosser

R.J.

. Modified endoscopic medial maxillectomy for chronic maxillary sinusitis. Am J Rhinol 20: 317–319, 2006.

20.

Shatz

. Management of recurrent sinus disease in children with cystic fibrosis: A combined approach. Otolaryngol Head Neck Surg 135: 248–252, 2006.

21.

Cho

D.Y.

, and Hwang

P.H.

. Results of endoscopic maxillary mega-antrostomy in recalcitrant maxillary sinusitis. Am J Rhinol 22: 658–662, 2008.

22.

Henriksson

, Westrin

K.M.

, Karpati

. Nasal polyps in cystic fibrosis: Clinical endoscopic study with nasal lavage fluid analysis. Chest 121: 40–47, 2002.

23.

Hadfield

P.J.

, Rowe-Jones

J.M.

, and Mackay

I.S.

. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology 38: 63–65, 2000.

24.

Lim

, Citardi

M.J.

, and Leong

J.L.

. Topical antimicrobials in the management of chronic rhinosinusitis: A systematic review. Am J Rhinol 22: 381–389, 2008.

25.

Cimmino

, Nardone

, Cavaliere

. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch Otolaryngol Head Neck Surg 131: 1097–1101, 2005.

26.

Raynor

E.M.

, Butler

, Guill

. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Arch Otolaryngol Head Neck Surg 126: 581–583, 2000.

27.

Tomooka

L.T.

, Murphy

, and Davidson

T.M.

. Clinical study and literature review of nasal irrigation. Laryngoscope 110: 1189–1193, 2000.

28.

Passalacqua

, Ciprandi

, and Canonica

G.W.

. The nose-lung interaction in allergic rhinitis and asthma: United airways disease. Curr Opin Allergy Clin Immunol 1: 7–13, 2001.

29.

Senior

B.A.

, and Kennedy

D.W.

. Management of sinusitis in the asthmatic patient. Ann Allergy Asthma Immunol 77: 6–15, 1996.

30.

Senior

B.A.

, Kennedy

D.W.

, Tanabodee

. Long-term results of functional endoscopic sinus surgery. Laryngoscope 108: 151–157, 1998.

31.

Madonna

, Isaacson

, Rosenfeld

R.M.

. Effect of sinus surgery on pulmonary function in patients with cystic fibrosis. Laryngoscope 107: 328–331, 1997.

32.

Zemanick

E.T.

, Harris

J.K.

, Conway

. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: Opportunities and challenges to therapy. J Cyst Fibros 9: 1–16, 2011.

33.

Khalid

A.N.

, Mace

, and Smith

T.L.

. Outcomes of sinus surgery in adults with cystic fibrosis. Otolaryngol Head Neck Surg 141: 358–363, 2009.